Wearable Injectors: The Perception of Inherent Expense and Complexity

Any discussion on wearable injectors is almost inevitably going to start with the rise of biopharmaceuticals. It is these novel therapies, both with huge potential therapeutic benefits and significant practical challenges that will, when formulated for subcutaneous delivery, drive the growth of the wearable injector market.

A number of biologic therapies will, by their nature, have high volumes and viscosities, making it increasingly apparent that a standard pen or autoinjector device is not a suitable administration system for these drugs.